Santen Pharmaceutical
4536.T
$9.53
Share price
0.07%
Change (1 day)
12.91%
Change (1 year)
Categories
Revenue for Santen Pharmaceutical (4536.T)
Revenue in 2023 (TTM): $2.12 B
According to Santen Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $2.12 B. In 2022 the company made a revenue of $2.03 B a decrease over the years 2021 revenue that were of $2.35 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Santen Pharmaceutical from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $2.12 B | 4.41% |
| 2022 | $2.03 B | -13.48% |
| 2021 | $2.35 B | 3.59% |
| 2020 | $2.27 B | 1.97% |
| 2019 | $2.22 B | 7.08% |
| 2018 | $2.08 B | 7.74% |
| 2017 | $1.93 B | 6.1% |
| 2016 | $1.82 B | 13.26% |
| 2015 | $1.60 B | 11.41% |
| 2014 | $1.44 B | 2.7% |
| 2013 | $1.40 B | -1.39% |
| 2012 | $1.42 B | -1.84% |
| 2011 | $1.45 B | 17.79% |
| 2010 | $1.23 B | 5.46% |
| 2009 | $1.16 B |